Etienne Karita

Q: What Schools Are Affiliated With Etienne Karita

Etienne Karita is affiliated with the following schools: Emory University, University of Rwanda, University of Cape Town, University of California, San Francisco, University of the Witwatersrand

Etienne Karita's AcademicInfluence.com Rankings

Etienne Karita

Biology

#14649

World Rank

#18456

Historical Rank

Biotechnology

#296

World Rank

#298

Historical Rank

Molecular Biology

#2531

World Rank

#2572

Historical Rank

biology Degrees

Download Badge

Biology

Etienne Karita's Degrees

PhD Biomedical Sciences University of California, San Francisco
Masters Molecular Biology University of Rwanda
Bachelors Biotechnology University of Rwanda

Why Is Etienne Karita Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Etienne Karita is a Rwandan scientist who has been researching HIV/AIDS in Rwanda since the mid-1980s. He has held numerous leadership positions in different organizations that are working to control HIV in Rwanda. Some of his work is concentrated on preventing mother to child transmission of HIV and in collaboration with Projet San Francisco, he has studied HIV in discordant couples.

(See a Problem?)

Etienne Karita's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Microfluidics-based diagnostics of infectious diseases in the developing world (2011) (691)
New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data (2008) (586)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm (2009) (579)
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 (2009) (346)
Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. (1991) (314)
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. (2010) (257)
Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda (1999) (238)
Infective and anti-infective properties of breastmilk from HIV-1-infected women (1993) (224)
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort (2016) (215)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (2018) (214)
Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy (2007) (194)
HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. (1999) (192)
Rwanda 20 years on: investing in life (2014) (176)
CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa (2009) (165)
Sexual practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counselling programme for men (2001) (162)
Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. (1994) (161)
Effect of HIV‐1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992–1994 (1998) (147)
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. (1999) (142)
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial (2010) (138)
Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities (2007) (131)
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. (2011) (130)
Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa (2007) (125)
Role of donor genital tract HIV-1 diversity in the transmission bottleneck (2011) (118)
Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda (2006) (118)
HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. (1999) (114)
Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. (1996) (107)
Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. (1991) (107)
Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa (2010) (100)
An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. (1994) (98)
Male circumcision, sexually transmitted disease, and risk of HIV. (1995) (97)
Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study (2009) (92)
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa (2013) (91)
Knowledge, use, and concerns about contraceptive methods among sero-discordant couples in Rwanda and Zambia. (2009) (87)
Mobile device for disease diagnosis and data tracking in resource-limited settings. (2013) (85)
Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. (1997) (82)
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage (2017) (82)
Role of traditional birth attendants in preventing perinatal transmission of HIV. (2002) (80)
Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study (2010) (80)
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates. (2010) (80)
HIV infection, malaria, and pregnancy: a prospective cohort study in Kigali, Rwanda. (2002) (77)
Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. (1993) (74)
Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native Africans (2006) (72)
Seroincidence of HIV‐1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988–1992 (1994) (67)
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. (2016) (66)
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. (2013) (65)
Voluntary Counseling and Testing for HIV Among Pregnant Women Presenting in Labor in Kigali, Rwanda (2002) (65)
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. (2010) (63)
Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia. (2013) (55)
Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. (1994) (54)
Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth (2013) (53)
Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa (2011) (53)
Postnatal transmission of HIV-1 associated with breast abscess (1992) (52)
Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. (2013) (49)
Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients (2015) (49)
Low birthweight in infants born to African HIV-infected women: relationship with maternal body weight during pregnancy: Pregnancy and HIV Study Group (EGE). (1999) (49)
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults (2015) (47)
Knowledge and Perceptions of Couples' Voluntary Counseling and Testing in Urban Rwanda and Zambia: A Cross-Sectional Household Survey (2011) (47)
Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission (2015) (46)
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. (2013) (46)
Infective and anti‐infective properties of breastmilk from HIV‐1‐infected women (1994) (44)
Influence network effectiveness in promoting couples’ HIV voluntary counseling and testing in Kigali, Rwanda (2012) (44)
Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). (1999) (43)
African-led health research and capacity building- is it working? (2020) (43)
Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa (2012) (41)
The Relationship Between Alcohol Consumption and Unprotected Sex Among Known HIV-discordant Couples in Rwanda and Zambia (2008) (40)
Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection (2012) (39)
Voluntary confidential HIV testing for couples in Kigali, Rwanda (1993) (36)
Human Leukocyte Antigen Variants B*44 and B*57 Are Consistently Favorable during Two Distinct Phases of Primary HIV-1 Infection in Sub-Saharan Africans with Several Viral Subtypes (2011) (36)
Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression (1999) (35)
Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda (2013) (35)
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens (2016) (33)
The Evolution of Voluntary Testing and Counseling as an HIV Prevention Strategy (2002) (33)
Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women (2000) (31)
The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia (2008) (31)
Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience (2015) (31)
Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda. (2007) (30)
Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice (2016) (28)
Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa (2012) (27)
Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials (2008) (26)
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: Implications for AIDS vaccine development using Sendai virus vectors (2011) (26)
Female sex workers in Kigali, Rwanda: a key population at risk of HIV, sexually transmitted infections, and unplanned pregnancy (2019) (25)
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study (2020) (25)
HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda. (2004) (25)
Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples. (2015) (25)
Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth (2016) (25)
Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994. (1999) (24)
HLA-B*57 versus HLA-B*81 in HIV-1 Infection: Slow and Steady Wins the Race? (2013) (24)
Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV‐1ANT‐70 isolate in human sera from different geographic regions (1994) (23)
Pregnancy, body weight and human immunodeficiency virus infection in African women: a prospective cohort study in Kigali (Rwanda), 1992-1994. Pregnancy and HIV Study Group (EGE). (1998) (22)
Malaria, HIV and pregnancy. (2003) (21)
HIV infection and engagement in HIV care cascade among men who have sex with men and transgender women in Kigali, Rwanda: a cross‐sectional study (2020) (21)
Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda (2019) (21)
Estimating the seroincidence of HIV‐1 in the general adult population in Kigali, Rwanda (1993) (20)
Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy (2017) (20)
Molecular investigation of recurrent tuberculosis in patients from Rwanda. (2007) (20)
TAPI polymorphisms in several human ethnic groups: characteristics, evolution, and genotyping strategies. (2001) (19)
Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on ‘Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines’, 31 January–2 February 2006, IAVI, New York, USA (2007) (18)
Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? (2004) (18)
β2-microglobulin as a predictor of death in HIV‐infected women from Kigali, Rwanda (1994) (18)
CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data (2015) (17)
Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa (2017) (16)
Predictors of HIV serostatus among HIV discordant couples in Lusaka, Zambia and female antenatal clinic attendants in Kigali, Rwanda. (2005) (16)
VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120 (2019) (16)
HIV-infected Rwandan women have a high frequency of long-term survival (2007) (15)
HIV testing and counselling couples together for affordable HIV prevention in Africa (2018) (15)
Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates. (2014) (14)
Antiretroviral treatment in Africa. (1997) (14)
Genotyping TAP2 variants in North American Caucasians, Brazilians, and Africans (2001) (13)
Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in Rwanda (2020) (13)
Macrophage-tropism of HIV-1 isolates of different genetic subtypes. (1997) (13)
Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection (2019) (12)
What the better half is thinking: A comparison of men’s and women’s responses and agreement between spouses regarding reported sexual and reproductive behaviors in Rwanda (2009) (12)
Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions (2014) (12)
Promotion of couples’ voluntary HIV counseling and testing: a comparison of influence networks in Rwanda and Zambia (2016) (12)
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria (2021) (11)
A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations (2017) (11)
New TAP2 polymorphisms in Africans. (1998) (11)
Molecular and Phylogeographic Analysis of Human Immuno-deficiency Virus Type 1 Strains Infecting Treatment-naive Patients from Kigali, Rwanda (2012) (10)
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa (2014) (10)
Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein. (2015) (10)
Serum retinol and HIV-1 RNA viral load in rapid and slow progressors. (1998) (10)
Daily Acyclovir Delays HIV-1 Disease Progression Among HIV-1/HSV-2 Dually-Infected Persons: A Randomized Trial (2010) (10)
Motivational interviewing to promote long acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy. (2019) (9)
HIV transmission in discordant couples in Africa in the context of antiretroviral therapy availability (2018) (9)
Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery (2020) (9)
Serum retinol and HIV-1 RNA viral load in rapid and slow progressors. (1998) (9)
Rwandan stakeholder perspectives of integrated family planning and HIV services (2018) (9)
Overestimation of the South African HIV incidence using the BED IgG assay? (2007) (9)
Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis. (2019) (9)
Human Immunodeficiency Virus type 1 elite neutralizers (2009) (9)
The Relationship Between Alcohol Consumption and Unprotected Sex Among Known HIV-discordant Couples in Rwanda and Zambia (2008) (9)
HIV Infection among STD Patients—Kigali, Rwanda, 1988 to 1991 (1993) (9)
The contribution of HIV-discordant relationships to new HIV infections: a rebuttal. (2011) (8)
CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus (2017) (8)
Excess morbidity related to HIV infection. (1994) (8)
Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women (2015) (8)
Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface (2019) (8)
Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis. (2006) (8)
A novel 24-base pair deletion in the coding region of CCR5 in an African population. (2007) (7)
Cost‐effectiveness of couples’ voluntary HIV counselling and testing in six African countries: a modelling study guided by an HIV prevention cascade framework (2020) (7)
Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries (2017) (7)
Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda. (2018) (7)
Predictors of HIV seropositivity following intrapartum voluntary counseling and testing among Rwandan women (2003) (6)
Rare and new V3 loop variants in HIV-1-positive long-term non-progressors from Rwanda. (2002) (6)
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes (2020) (6)
Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda. (2018) (6)
Assessment of Anti–HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different Populations (2016) (6)
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events (2012) (5)
A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission Pairs. (2012) (5)
Cost per insertion and couple year of protection for postpartum intrauterine devices and implants provided during service scale-up in Kigali, Rwanda. (2019) (5)
When one can infect two: a reflection on the impact of HIV discordance on child HIV infection (2010) (5)
Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples. (2021) (5)
Development and Uptake of Long-Acting Reversible Contraception Services in Rwanda, 2009-2016. (2019) (5)
Characterization of CD8+ T lymphocytes in chronic HIV-1 subtype A infection in Rwandan women. (2005) (4)
Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa (2018) (4)
Cross-sectional assessment of determinants of STIs among men who have sex with men and transgender women in Kigali, Rwanda (2021) (4)
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial (2020) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Broadly neutralizing, MN-like PND-directed antibodies in Rwandan children with long-term HIV1 infection. (1995) (4)
An Exploratory Analysis of Factors Associated With Interest in Postpartum Intrauterine Device Uptake Among Pregnant Women and Couples in Kigali, Rwanda (2019) (4)
Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk. (1997) (4)
Effect of Seasonal Variation on Adult Clinical Laboratory Parameters in Rwanda, Zambia, and Uganda: Implications for HIV Biomedical Prevention Trials (2014) (4)
Division of HIV/AIDS Prevention - Surveillance and Epidemiology 2002 Publications (2003) (4)
High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples (2015) (3)
Sexual practices of HIV concordant and discordant heterosexual couples in Rwanda: Effects of a testing and counseling program for men (2001) (3)
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome (2021) (3)
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa (2021) (3)
Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations. (2017) (3)
Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection (2016) (3)
HIVs and AIDS in East Africa. (1994) (3)
Associations between punitive policies and legal barriers to consensual same-sex sexual acts and HIV among gay men and other men who have sex with men in sub-Saharan Africa: a multicountry, respondent-driven sampling survey. (2023) (3)
The presence or absence of gp120/gp160 bands on indeterminate western blots: predictive value for HIV seroconversion. (1993) (3)
Uptake of long acting reversible contraception following integrated couples HIV and fertility goal-based family planning counselling in Catholic and non-Catholic, urban and rural government health centers in Kigali, Rwanda (2020) (3)
Original article Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda (1999) (3)
Postpartum long-acting contraception uptake and service delivery outcomes after a multilevel intervention in Kigali, Rwanda (2020) (3)
Novel alleles at the lymphotoxin alpha (LTalpha) locus mark extended HLA haplotypes in native Africans. (2001) (3)
Cost per insertion and couple year of protection for post-partum intrauterine devices and implants provided during service scale-up in Kigali, Rwanda. (2018) (3)
WHO's new guidelines for antiretroviral treatment (2013) (2)
Mother to Infant Transmission During and After Seroconversion in Kigali, Rwanda (1993) (2)
The Relationship Between Sexual Behavior Stigma and Depression Among Men Who have Sex with Men and Transgender Women in Kigali, Rwanda: a Cross-sectional Study (2021) (2)
Evaluation of a multi-level intervention to improve post-partum intrauterine device services in Rwanda (2018) (2)
Perinatal Study of HIV-1 in Kigali, Rwanda: Estimation of the Mother-to-Child Transmission Rate and Analysis of its Determinants (1992) (2)
P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients (2009) (2)
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign (2022) (2)
Cost per insertion and couple year of protection for postpartum intrauterine devices and implants provided during service scale-up in Kigali, Rwanda (2019) (2)
Reply to Yang et al. (2013) (2)
P20-14. Co- and superinfection of partners in a cohort of couples previously infected by genotypically different viruses in Kigali (2009) (2)
Low birthweight in infants born to HIV-infected women: relation with maternal body weight during pregnancy. A prospective cohort study in Kigali (Rwanda), 1992-1994 (1997) (2)
Human Immunodeﬁciency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identiﬁed by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm (cid:1) † (2009) (2)
Etiologies of genital inflammation and ulceration in symptomatic Rwandan men and women responding to radio promotions of free screening and treatment services (2021) (2)
Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans (2022) (2)
ART use and HIV transmission among discordant couples in non-research settings in Kigali, Rwanda. (2021) (2)
Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts (2021) (2)
Cost per insertion and couple year of protection for postpartum intrauterine devices and implants provided during service scale-up in Kigali, Rwanda. (2019) (2)
Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions (2014) (1)
Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women (2021) (1)
P06-08. Building an African HIV preventive trial network (2009) (1)
Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda (2018) (1)
HIV-1 viral control varies by viral subtype in a large cohort of African adults with incident HIV-1 infection. (2019) (1)
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial (2022) (1)
Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda (2021) (1)
Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda (2012) (1)
Development of Broadly Neutralizing Antibody Responses in a Large Sub-Sahara African HIV Primary Infection Cohort (2013) (1)
Cross-sectional assessment of government health center needs to implement long-acting reversible contraception services in rural Rwanda (2019) (1)
Hepatitis B and HIV type 1 co-infection in pregnant African women (2002) (1)
Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic (2013) (0)
O983 HIV incidence during pregnancy in a Kigali referral maternity (2009) (0)
Knowledge and Perceptions of Couples ' Voluntary Counseling and Testing in Urban Rwanda and Zambia : A Cross-Sectional Household Survey April (2018) (0)
Abstract session IV: BMT: The power of gene polymorphism assessment32-OR: HLA-B*4415 is a common allele in Rwandans (2007) (0)
Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda (2012) (0)
Antibiotic-resistant Neisseria gonorrhoeae and changes to the 2019 Rwandan National STI Guidelines (2021) (0)
Infection: Slow and Steady Wins the Race? HLA-B*57 versus HLA-B*81 in HIV-1 (2014) (0)
P-C2 Characterization of the early antibody landscape in HIV-1 infected individuals who develop poor to elite levels of neutralization breadth (2017) (0)
Contents Vol. 17, 2000 (2000) (0)
ROAD TO BUILDING AND SUSTAINING NOVEL CLINICAL RESEARCH CAPACITY IN RESOURCE-LIMITED SETTINGS: LESSONS LEARNT SO FAR FROM RWANDA (2017) (0)
Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned (2012) (0)
HIV Seroprevalence Among STD Patients in Kigali, Rwanda During the Four-Year Period, 1988-1991 (1992) (0)
Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials (2012) (0)
Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda (2012) (0)
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa (2009) (0)
Original articles 98 Seroprevalence and incidence of genital ulcer infections in a rural Ugandan (1999) (0)
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
Timing of Mother-to Child Transmission of HIV-1 as Determinated by Nested Polymerase Chain Reaction — A Cohort Study in Kigali, Rwanda (1994) (0)
A cross sectional study in Eastern & Southern Africa to characterize laboratory reference intervals in healthy adults from HIV prevention trials, AIDS Vaccine, Cape Town, SOUTH AFRICA, Oct 13-15 (2008) (0)
Milk HIV-1 IgG SIgA and IgM in a Cohort of HIV-1 Infected Mothers Kigali, Rwanda (1988-1990) (1992) (0)
HLA-B(star)57 versus HLA-B(star)81 in HIV-1 Infection: Slow and Steady Wins the Race? (0)
Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials (2012) (0)
Enrollment and screening failure in 2,424 African volunteers recruited for a multi-centre study of laboratory reference ranges in preparation for HIV vaccine clinical trials, (2006) (0)
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors (2022) (0)
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection (2012) (0)
Author response: Identifying the immune interactions underlying HLA class I disease associations (2020) (0)
HIV disease progression compared by linkage status in Rwanda and Zambia (2012) (0)
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa (2021) (0)
Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa (2012) (0)
A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis (2017) (0)
Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. (2022) (0)
Immune exposure to a specific sequence of antibody escape variants could program long-term potential for neutralization breadth in subtype A HIV-1 infection (P6161) (2013) (0)
Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda (2012) (0)
HIV disease progression compared by linkage status in Rwanda and Zambia (2012) (0)
A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence (2022) (0)
Implementation and evaluation of a large-scale postpartum family planning program in Rwanda: study protocol for a clinic-randomized controlled trial (2022) (0)
Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009). (2007) (0)
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection (2012) (0)
Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned (2012) (0)
Analysis of the Relationship Between Founder Virus Fitness, Primary T Cell Response Breadth and Viral Control in Acute HIV-1 Infection (2013) (0)
African Early Infection Cohort as a Platform for Vaccine Discovery: The IAVI Protocol C Experience (2014) (0)
the IAVI Collaborative Seroprevalence and Incidence Study Team.Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-se (2007) (0)
HLA Amino Acid Residues in HIV-1 Infection 2 (2017) (0)
A mixed-methods study of factors influencing postpartum intrauterine device uptake after family planning counseling among women in Kigali, Rwanda (2022) (0)

This paper list is powered by the following services:

Other Resources About Etienne Karita

en.wikipedia.org

What Schools Are Affiliated With Etienne Karita?

Etienne Karita is affiliated with the following schools:

Etienne Karita's Academic­Influence.com Rankings

Etienne Karita's Degrees

Why Is Etienne Karita Influential?

Etienne Karita's Published Works

Published Works

Other Resources About Etienne Karita

What Schools Are Affiliated With Etienne Karita?

Etienne Karita's AcademicInfluence.com Rankings